Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 44

    1.

    AMPK-deficient mice are resistant to the metabolic effects of resveratrol.

    Um JH, Park SJ, Kang H, Yang S, Foretz M, McBurney MW, Kim MK, Viollet B, Chung JH.

    Diabetes. 2009 Nov 23. [Epub ahead of print]PMID: 19934007 [PubMed - as supplied by publisher]Related articles

    2.

    Targeting the AMPK pathway for the treatment of Type 2 diabetes.

    Viollet B, Lantier L, Devin-Leclerc J, Hebrard S, Amouyal C, Mounier R, Foretz M, Andreelli F.

    Front Biosci. 2009 Jan 1;14:3380-400. Review.PMID: 19273282 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    AMPK: Lessons from transgenic and knockout animals.

    Viollet B, Athea Y, Mounier R, Guigas B, Zarrinpashneh E, Horman S, Lantier L, Hebrard S, Devin-Leclerc J, Beauloye C, Foretz M, Andreelli F, Ventura-Clapier R, Bertrand L.

    Front Biosci. 2009 Jan 1;14:19-44. Review.PMID: 19273052 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives.

    Viollet B, Guigas B, Leclerc J, Hébrard S, Lantier L, Mounier R, Andreelli F, Foretz M.

    Acta Physiol (Oxf). 2009 May;196(1):81-98. Epub 2009 Feb 19.PMID: 19245656 [PubMed - in process]Related articles

    5.

    Important role for AMPKalpha1 in limiting skeletal muscle cell hypertrophy.

    Mounier R, Lantier L, Leclerc J, Sotiropoulos A, Pende M, Daegelen D, Sakamoto K, Foretz M, Viollet B.

    FASEB J. 2009 Jul;23(7):2264-73. Epub 2009 Feb 23.PMID: 19237506 [PubMed - indexed for MEDLINE]Related articles

    6.

    AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex.

    Vernia S, Solaz-Fuster MC, Gimeno-Alcañiz JV, Rubio T, García-Haro L, Foretz M, de Córdoba SR, Sanz P.

    J Biol Chem. 2009 Mar 27;284(13):8247-55. Epub 2009 Jan 26.PMID: 19171932 [PubMed - indexed for MEDLINE]Related articles

    7.

    Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice.

    Troy S, Soty M, Ribeiro L, Laval L, Migrenne S, Fioramonti X, Pillot B, Fauveau V, Aubert R, Viollet B, Foretz M, Leclerc J, Duchampt A, Zitoun C, Thorens B, Magnan C, Mithieux G, Andreelli F.

    Cell Metab. 2008 Sep;8(3):201-11.PMID: 18762021 [PubMed - indexed for MEDLINE]Related articles

    8.

    AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation.

    Mishra R, Cool BL, Laderoute KR, Foretz M, Viollet B, Simonson MS.

    J Biol Chem. 2008 Apr 18;283(16):10461-9. Epub 2008 Feb 4.PMID: 18250161 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Targeting AMP-activated protein kinase as a novel therapeutic approach for the treatment of metabolic disorders.

    Viollet B, Mounier R, Leclerc J, Yazigi A, Foretz M, Andreelli F.

    Diabetes Metab. 2007 Dec;33(6):395-402. Epub 2007 Nov 7. Review.PMID: 17997341 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Protein kinase CK2 acts as a signal molecule switching between the NDPK-A/AMPK 1 complex and NDPK-B.

    Crawford RM, Treharne KJ, Arnaud-Dabernat S, Daniel JY, Foretz M, Viollet B, Mehta A.

    FASEB J. 2007 Oct;21(12):3398. No abstract available. PMID: 17905730 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Mechanism of action of A-769662, a valuable tool for activation of AMP-activated protein kinase.

    Göransson O, McBride A, Hawley SA, Ross FA, Shpiro N, Foretz M, Viollet B, Hardie DG, Sakamoto K.

    J Biol Chem. 2007 Nov 9;282(45):32549-60. Epub 2007 Sep 12.PMID: 17855357 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Haptoglobin is degraded by iron in C57BL/6 mice: a possible link with endoplasmic reticulum stress.

    Faye A, Ramey G, Foretz M, Vaulont S.

    Blood Cells Mol Dis. 2007 Nov-Dec;39(3):229-37. Epub 2007 Jul 17.PMID: 17644369 [PubMed - indexed for MEDLINE]Related articles

    13.

    S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase.

    Aguilar V, Alliouachene S, Sotiropoulos A, Sobering A, Athea Y, Djouadi F, Miraux S, Thiaudière E, Foretz M, Viollet B, Diolez P, Bastin J, Benit P, Rustin P, Carling D, Sandri M, Ventura-Clapier R, Pende M.

    Cell Metab. 2007 Jun;5(6):476-87.PMID: 17550782 [PubMed - indexed for MEDLINE]Related articles

    14.

    Activation of 5'-AMP-activated kinase with diabetes drug metformin induces casein kinase Iepsilon (CKIepsilon)-dependent degradation of clock protein mPer2.

    Um JH, Yang S, Yamazaki S, Kang H, Viollet B, Foretz M, Chung JH.

    J Biol Chem. 2007 Jul 20;282(29):20794-8. Epub 2007 May 24.PMID: 17525164 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    AMP-activated protein kinase-independent inhibition of hepatic mitochondrial oxidative phosphorylation by AICA riboside.

    Guigas B, Taleux N, Foretz M, Detaille D, Andreelli F, Viollet B, Hue L.

    Biochem J. 2007 Jun 15;404(3):499-507.PMID: 17324122 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Protein kinase CK2 acts as a signal molecule switching between the NDPK-A/AMPK alpha1 complex and NDPK-B.

    Crawford RM, Treharne KJ, Arnaud-Dabernat S, Daniel JY, Foretz M, Viollet B, Mehta A.

    FASEB J. 2007 Jan;21(1):88-98. Epub 2006 Nov 29. Retraction in: Crawford RM, Treharne KJ, Arnaud-Dabernat S, Daniel JY, Foretz M, Viollet B, Mehta A. FASEB J. 2007 Oct;21(12):3398. PMID: 17135357 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy.

    Lee MJ, Feliers D, Mariappan MM, Sataranatarajan K, Mahimainathan L, Musi N, Foretz M, Viollet B, Weinberg JM, Choudhury GG, Kasinath BS.

    Am J Physiol Renal Physiol. 2007 Feb;292(2):F617-27. Epub 2006 Oct 3.PMID: 17018841 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver.

    Rencurel F, Foretz M, Kaufmann MR, Stroka D, Looser R, Leclerc I, da Silva Xavier G, Rutter GA, Viollet B, Meyer UA.

    Mol Pharmacol. 2006 Dec;70(6):1925-34. Epub 2006 Sep 20.PMID: 16988011 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Expression of uncoupling protein 3 and GLUT4 gene in skeletal muscle of preterm newborns: possible control by AMP-activated protein kinase.

    Brauner P, Kopecky P, Flachs P, Kuda O, Vorlicek J, Planickova L, Vitkova I, Andreelli F, Foretz M, Viollet B, Kopecky J.

    Pediatr Res. 2006 Nov;60(5):569-75. Epub 2006 Sep 11.PMID: 16966355 [PubMed - indexed for MEDLINE]Related articles

    20.

    Understanding the molecular basis of the interaction between NDPK-A and AMPK alpha 1.

    Crawford RM, Treharne KJ, Arnaud-Dabernat S, Daniel JY, Foretz M, Viollet B, Mehta A.

    Mol Cell Biol. 2006 Aug;26(15):5921-31. Retraction in: Mol Cell Biol. 2008 Sep;28(18):5827. PMID: 16847342 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments.

    Laderoute KR, Amin K, Calaoagan JM, Knapp M, Le T, Orduna J, Foretz M, Viollet B.

    Mol Cell Biol. 2006 Jul;26(14):5336-47.PMID: 16809770 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Peroxisome proliferator-activated receptor-alpha-null mice have increased white adipose tissue glucose utilization, GLUT4, and fat mass: Role in liver and brain.

    Knauf C, Rieusset J, Foretz M, Cani PD, Uldry M, Hosokawa M, Martinez E, Bringart M, Waget A, Kersten S, Desvergne B, Gremlich S, Wahli W, Seydoux J, Delzenne NM, Thorens B, Burcelin R.

    Endocrinology. 2006 Sep;147(9):4067-78. Epub 2006 Jun 15.PMID: 16777972 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.

    Viollet B, Foretz M, Guigas B, Horman S, Dentin R, Bertrand L, Hue L, Andreelli F.

    J Physiol. 2006 Jul 1;574(Pt 1):41-53. Epub 2006 Apr 27. Review.PMID: 16644802 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    [Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases]

    Foretz M, Taleux N, Guigas B, Horman S, Beauloye C, Andreelli F, Bertrand L, Viollet B.

    Med Sci (Paris). 2006 Apr;22(4):381-8. Review. French. PMID: 16597407 [PubMed - indexed for MEDLINE]Related articles

    25.

    [From cancer to diabetes treatment : the tumor suppressor LKB1 as a new pharmacological target]

    Foretz M, Guigas B, Viollet B.

    Med Sci (Paris). 2006 Apr;22(4):348-50. French. No abstract available. PMID: 16597397 [PubMed - indexed for MEDLINE]Related articles

    26.

    Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding.

    Bady I, Marty N, Dallaporta M, Emery M, Gyger J, Tarussio D, Foretz M, Thorens B.

    Diabetes. 2006 Apr;55(4):988-95.PMID: 16567520 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin inhibit hepatic glucose phosphorylation by an AMP-activated protein kinase-independent effect on glucokinase translocation.

    Guigas B, Bertrand L, Taleux N, Foretz M, Wiernsperger N, Vertommen D, Andreelli F, Viollet B, Hue L.

    Diabetes. 2006 Apr;55(4):865-74.PMID: 16567505 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin.

    Andreelli F, Foretz M, Knauf C, Cani PD, Perrin C, Iglesias MA, Pillot B, Bado A, Tronche F, Mithieux G, Vaulont S, Burcelin R, Viollet B.

    Endocrinology. 2006 May;147(5):2432-41. Epub 2006 Feb 2.PMID: 16455782 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Regulation of glucagon secretion by glucose transporter type 2 (glut2) and astrocyte-dependent glucose sensors.

    Marty N, Dallaporta M, Foretz M, Emery M, Tarussio D, Bady I, Binnert C, Beermann F, Thorens B.

    J Clin Invest. 2005 Dec;115(12):3545-53.PMID: 16322792 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver.

    Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, Kahn A, Thorens B, Vaulont S, Viollet B.

    Diabetes. 2005 May;54(5):1331-9.PMID: 15855317 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Impaired glucose homeostasis in mice lacking the alpha1b-adrenergic receptor subtype.

    Burcelin R, Uldry M, Foretz M, Perrin C, Dacosta A, Nenniger-Tosato M, Seydoux J, Cotecchia S, Thorens B.

    J Biol Chem. 2004 Jan 9;279(2):1108-15. Epub 2003 Oct 27.PMID: 14581480 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Study of the regulation by nutrients of the expression of genes involved in lipogenesis and obesity in humans and animals.

    Delzenne N, Ferré P, Beylot M, Daubioul C, Declercq B, Diraison F, Dugail I, Foufelle F, Foretz M, Mace K, Reimer R, Palmer G, Rutter G, Tavare J, Van Loo J, Vidal H.

    Nutr Metab Cardiovasc Dis. 2001 Aug;11(4 Suppl):118-21. Review.PMID: 11894744 [PubMed - indexed for MEDLINE]Related articles

    33.

    Sterol-regulatory-element-binding protein 1c mediates insulin action on hepatic gene expression.

    Ferré P, Foretz M, Azzout-Marniche D, Bécard D, Foufelle F.

    Biochem Soc Trans. 2001 Aug;29(Pt 4):547-52. Review.PMID: 11498026 [PubMed - indexed for MEDLINE]Related articles

    34.

    Sterol regulatory element-binding protein-1c mimics the negative effect of insulin on phosphoenolpyruvate carboxykinase (GTP) gene transcription.

    Chakravarty K, Leahy P, Becard D, Hakimi P, Foretz M, Ferre P, Foufelle F, Hanson RW.

    J Biol Chem. 2001 Sep 14;276(37):34816-23. Epub 2001 Jul 6.PMID: 11443121 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase.

    Woods A, Azzout-Marniche D, Foretz M, Stein SC, Lemarchand P, Ferré P, Foufelle F, Carling D.

    Mol Cell Biol. 2000 Sep;20(18):6704-11.PMID: 10958668 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes.

    Azzout-Marniche D, Bécard D, Guichard C, Foretz M, Ferré P, Foufelle F.

    Biochem J. 2000 Sep 1;350 Pt 2:389-93.PMID: 10947952 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    The inhibitory effect of glucose on phosphoenolpyruvate carboxykinase gene expression in cultured hepatocytes is transcriptional and requires glucose metabolism.

    Cournarie F, Azzout-Marniche D, Foretz M, Guichard C, Ferre P, Foufelle F.

    FEBS Lett. 1999 Nov 5;460(3):527-32.PMID: 10556529 [PubMed - indexed for MEDLINE]Related articles

    38.

    Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes.

    Foretz M, Guichard C, Ferré P, Foufelle F.

    Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12737-42.PMID: 10535992 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.
    40.

    ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose.

    Foretz M, Pacot C, Dugail I, Lemarchand P, Guichard C, Le Lièpvre X, Berthelier-Lubrano C, Spiegelman B, Kim JB, Ferré P, Foufelle F.

    Mol Cell Biol. 1999 May;19(5):3760-8.PMID: 10207099 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    AMP-activated protein kinase inhibits the glucose-activated expression of fatty acid synthase gene in rat hepatocytes.

    Foretz M, Carling D, Guichard C, Ferré P, Foufelle F.

    J Biol Chem. 1998 Jun 12;273(24):14767-71.PMID: 9614076 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Borrelia burgdorferi sensu stricto, a bacterial species "made in the U.S.A."?

    Marti Ras N, Postic D, Foretz M, Baranton G.

    Int J Syst Bacteriol. 1997 Oct;47(4):1112-7.PMID: 9336916 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Induction of fatty acid synthase and S14 gene expression by glucose, xylitol and dihydroxyacetone in cultured rat hepatocytes is closely correlated with glucose 6-phosphate concentrations.

    Mourrieras F, Foufelle F, Foretz M, Morin J, Bouche S, Ferre P.

    Biochem J. 1997 Sep 1;326 ( Pt 2):345-9.PMID: 9291103 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Phylogenetic analysis of Borrelia burgdorferi sensu stricto by arbitrarily primed PCR and pulsed-field gel electrophoresis.

    Foretz M, Postic D, Baranton G.

    Int J Syst Bacteriol. 1997 Jan;47(1):11-8.PMID: 8995796 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...